Login / Signup

Argipressin for prevention of blood loss during liver resection: a study protocol for a randomised, placebo-controlled, double-blinded trial (ARG-01).

Ellinor WisénAndreas KvarnströmLena Sand-BownMagnus RizellAldina PivodicSven-Erik RickstenKristina Svennerholm
Published in: BMJ open (2023)
ClinicalTrials.gov, NCT05293041 and EudraCT, 2021-001806-32.
Keyphrases
  • placebo controlled
  • phase iii
  • phase ii
  • double blind
  • study protocol
  • clinical trial
  • open label
  • phase ii study
  • randomized controlled trial
  • squamous cell carcinoma
  • radiation therapy
  • rectal cancer